Last reviewed · How we verify
NCT06365190
Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease
NA trial testing transcranial magnetic stimulation in Transcranial Magnetic Stimulation in 47 participants. Participants enrolled and being followed up; not accepting new ones.
31 July 2024
Quick facts
| Lead sponsor | Anhui Medical University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 47 |
| Start date | 6 April 2020 |
| Primary completion | 31 July 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- transcranial magnetic stimulation — full drug profile →
- Pharmacotherapy（antiparkinsonian drugs） — full drug profile →
Conditions studied
- Transcranial Magnetic Stimulation — all drugs for Transcranial Magnetic Stimulation →
- Parkinson's Disease — all drugs for Parkinson's Disease →
Sponsor
Anhui Medical University
Who can join
Adults 40 to 80, any sex, with Transcranial Magnetic Stimulation or Parkinson's Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Previous studies have shown that repetitive transcranial magnetic stimulation(rTMS) can improve clinical symptoms of Parkinson's disease(PD). Continuous theta-burst stimulation(cTBS) is a novel rTMS protocol that produces physiological effects b acting on neurons in the brain, which can decrease the excitability of motor system. This study aims to explore the long-term effects of cTBS on improvement of movement symptoms in patients with PD.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06365190
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of transcranial magnetic stimulation
Trials testing the same drug.
- NCT07180654 — Menstrual Cycle TMS Plasticity Pilot · recruiting
- NCT07138677 — Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial · NA · recruiting
- NCT06837207 — Precision Transcranial Magnetic Stimulation for Depression Based on Orbital Frontal Cortex-habenula Circuitry · NA · not yet recruiting
- NCT06919172 — iTBS/fMRI Study of Apex Control · NA · recruiting
- NCT06383247 — The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkin · NA · recruiting
Other recruiting trials for Transcranial Magnetic Stimulation
Currently open trials in the same condition.
- NCT07264452 — Comparison of the Efficacy of Accelerated Intermittent Theta Burst Stimulation and Accelerated Continuous Theta Burst St · NA · recruiting
- NCT07176468 — Personalized iTBS in Real-World Clinical Settings for Schizophrenia · NA · recruiting
- NCT07138677 — Safty and Efficacy of MCI Network Guided TMS for Early Alzheimer's Disease: A Randomized, Double-blind Trial · NA · recruiting
- NCT06765642 — The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients. · NA · recruiting
- NCT06578429 — Deep TMS of Neural Circuits Associated With Stimulant Use Disorder · NA · recruiting
Other Anhui Medical University trials
Trials by the same sponsor.
- NCT07403591 — Mapsd Dual-target cTBS (Auditory Cortex and M1) for Generalized Anxiety Disorder · NA · not yet recruiting
- NCT07112612 — Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer · not yet recruiting
- NCT07112599 — Study of Predicting Lymph Node Metastasis of High-risk Prostate Cancer by Artificial Intelligence Multi-omics Analysis · recruiting
- NCT07176468 — Personalized iTBS in Real-World Clinical Settings for Schizophrenia · NA · recruiting
- NCT07486804 — Effects of taVNS Combined With tACS on Adolescents With Non-Suicidal Self-Injury · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06365190 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Anhui Medical University
- Last refreshed: 16 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06365190.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing